Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arboix A., Besses C., Acín P., Massons J. B., Florensa L., Oliveres M., Sans-Sabrafen J. Ischemic stroke as first manifestation of essential thrombocythemia. Report of six cases. Stroke. 1995 Aug;26(8):1463–1466. doi: 10.1161/01.str.26.8.1463. [DOI] [PubMed] [Google Scholar]
- Bucalossi A., Marotta G., Bigazzi C., Galieni P., Dispensa E. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis. Am J Hematol. 1996 May;52(1):14–20. doi: 10.1002/(SICI)1096-8652(199605)52:1<14::AID-AJH3>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
- Cancelas J. A., García-Avello A., García-Frade L. J. High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosis. Thromb Res. 1994 Sep 1;75(5):513–520. doi: 10.1016/0049-3848(94)90226-7. [DOI] [PubMed] [Google Scholar]
- Cortelazzo S., Finazzi G., Ruggeri M., Vestri O., Galli M., Rodeghiero F., Barbui T. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med. 1995 Apr 27;332(17):1132–1136. doi: 10.1056/NEJM199504273321704. [DOI] [PubMed] [Google Scholar]
- Hart R. G., Kanter M. C. Hematologic disorders and ischemic stroke. A selective review. Stroke. 1990 Aug;21(8):1111–1121. doi: 10.1161/01.str.21.8.1111. [DOI] [PubMed] [Google Scholar]
- Landi G., D'Angelo A., Boccardi E., Candelise L., Mannucci P. M., Nobile Orazio E., Morabito A. Hypercoagulability in acute stroke: prognostic significance. Neurology. 1987 Oct;37(10):1667–1671. doi: 10.1212/wnl.37.10.1667. [DOI] [PubMed] [Google Scholar]
- Rosendaal F. R. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol. 1997 Jul;34(3):171–187. [PubMed] [Google Scholar]
- Sacco R. L. Risk factors and outcomes for ischemic stroke. Neurology. 1995 Feb;45(2 Suppl 1):S10–S14. [PubMed] [Google Scholar]
- Wieczorek I., MacGregor I. R., Ludlam C. A. Low proteins C and S and activation of fibrinolysis in treated essential thrombocythemia. Am J Hematol. 1995 Aug;49(4):277–281. doi: 10.1002/ajh.2830490404. [DOI] [PubMed] [Google Scholar]